{"database": "lobbying", "table": "lobbying_activities", "rows": [[2467342, "708d46f0-595d-4194-817c-d3821e3a5c0d", "Q2", "HOLLAND & KNIGHT LLP", 18466, "VIATRIS INC", 2020, "second_quarter", "PHA", "Drug shortages, formulary tiering, National Defense Authorization Act (NDAA), biosimilar uptake, the consumer price index, generic drugs.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2020-07-16T08:01:29.370000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2467342"], "units": {}, "query_ms": 65.66940899938345, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}